Cell proliferative activity and expression of cell-cell adhesion factors (E-cadherin, alpha-, beta-, and gamma-catenin, and p120) in sarcomatoid renal cell carcinoma
K. Kuroiwa et al., Cell proliferative activity and expression of cell-cell adhesion factors (E-cadherin, alpha-, beta-, and gamma-catenin, and p120) in sarcomatoid renal cell carcinoma, J SURG ONC, 77(2), 2001, pp. 123-131
Background and Objectives: Sarcomatoid RCC (renal cell carcinoma) is an unc
ommon, but not rare, neoplasm which has been shown to have a much worse pro
gnosis than common RCC. The current study was designed to investigate the a
ssociation of proliferative activity and cell-cell adhesion molecules with
sarcomatoid RCC.
Methods: Proliferative activity (Ki-67 labeling index) and expression of ce
ll-cell adhesion associated molecules (E-cadherin, alpha-, beta-, and gamma
-catenin, and p120) were examined using immunohistochemical techniques in
11 cases of sarcomatoid RCC.
Results: In six patients with sarcomatous component more than 50%, five wer
e died within 24 month after diagnosis. The expression of these molecules w
ithin the carcinomatous and sarcomatous components of sarcomatoid RCC was c
ompared. The mean Ki-67 labeling index in the sarcomatous components (12.6%
) is statistically higher than in the carcinomatous components (3.7%) (P<0.
05). The expressions of E-cadherin, and <alpha>-, beta-, and gamma -catenin
were statistically decreased in the sarcomatous components compared to the
carcinomatous components. However, no differences were observed regarding
p120 immunostaining.
Conclusions: The findings of the current study suggest that the range of th
e sarcomatous component may be a prognostic factor in RCC, and the malignan
t behavior of sarcomatoid RCC is due to high cell proliferative activity an
d decreased expressions of E-cadherin and alpha-,beta-, and gamma -catenin
in the sarcomatous component. J. Surg. Oncol. 2001;77:123-131. (C) 2001 Wil
ey-Liss, Inc.